Number of patients n = 43
Male sex 36 (84%)
Ischemic cardiomyopathy 20 (47%)
Non-ischemic cardiomyopathy (DCM/sarcoidosis/HCM/amyloidosis/Brugada S/unclassified) 23 (53%) (10/3/2/1/1/6)
NYHA class (I/II/III/IV) (12/19/11/1)
ß-blocker use 31 (72%)
ACE-I or ARB use 28 (65%)
Cardiotonic agent use 7 (16%)
Antiarrhythmic drug use 13 (30%)
EF (%) 36, SD*: 15
CRT-D 16 (37%)